person

Tarik A.

Country
France
Department
hôpital beaujon - service hépatologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
95
Sites with multiple studies

Has run more than one trial at 95 of 199 partner sites.

Specializations

Viral Hepatitis Research

The investigator specializes in treating complex chronic viral hepatitis infections, with particular emphasis on Hepatitis B and Hepatitis D co-infections. Their research encompasses innovative therapeutic approaches for managing these conditions.

  • Chronic Hepatitis B Management
  • Hepatitis D Treatment Strategies
  • Viral Co-infection Therapeutics

Their work includes evaluation of novel antiviral treatments and long-term disease management strategies.

Immunological Therapeutics

The investigator focuses on immunotherapy approaches in hepatitis treatment, including research into targeted immunological interventions and novel therapeutic combinations. Their work explores immune response modulation in chronic viral infections.

  • Immunological Response Assessment
  • Combination Therapy Approaches
  • Long-term Treatment Outcomes

Their research includes evaluation of immune-based therapies and their effects on viral suppression.

Gastrointestinal Disorders

The investigator conducts research in eosinophilic gastrointestinal disorders, specifically focusing on eosinophilic gastritis and eosinophilic duodenitis. Their work includes assessment of novel therapeutic approaches for these conditions.

  • Eosinophilic Disease Management
  • Gastrointestinal Inflammation
  • Treatment Response Evaluation

Their research encompasses both adult and adolescent patient populations with inflammatory gastrointestinal conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.